Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:16 pm Sale |
2024-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Private Advisor Group, LLC | 0 0.000% |
-744,513 (Position Closed) |
Filing History |
| 2025-02-13 4:02 pm Sale |
2024-12-31 | 13G | Lumos Pharma, Inc. LUMO |
GOLDMAN SACHS GROUP INC GS |
0 0.000% |
-406,711 (Position Closed) |
Filing History |
| 2024-11-12 6:27 pm Purchase |
2024-09-30 | 13G | Lumos Pharma, Inc. LUMO |
Private Advisor Group, LLC | 744,513 9.160% |
744,513 (New Position) |
Filing History |
| 2024-10-25 10:43 am Sale |
2024-09-30 | 13G | Lumos Pharma, Inc. LUMO |
WELLS FARGO & CO WFC |
64,981 0.800% |
-352,070 (-84.42%) |
Filing History |
| 2024-02-09 7:14 pm Sale |
2023-12-29 | 13G | Lumos Pharma, Inc. LUMO |
GOLDMAN SACHS GROUP INC GS |
406,711 5.100% |
-62,691 (-13.36%) |
Filing History |
| 2024-02-06 09:57 am Purchase |
2023-12-31 | 13G | Lumos Pharma, Inc. LUMO |
WELLS FARGO & CO WFC |
417,051 5.300% |
417,051 (New Position) |
Filing History |
| 2023-11-29 4:30 pm Sale |
2023-11-27 | 13D | NEWLINK GENETICS CORP NLNK |
Blackstone Holdings II L.P. | 385,683 4.900% |
-82,462 (-17.61%) |
Filing History |
| 2023-06-20 06:05 am Sale |
2023-06-16 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 400,000 4.900% |
-96,891 (-19.50%) |
Filing History |
| 2023-06-02 11:14 am Sale |
2023-05-30 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,891 6.080% |
-146,447 (-22.76%) |
Filing History |
| 2023-05-25 12:10 pm Sale |
2023-05-24 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 643,338 7.870% |
-116,662 (-15.35%) |
Filing History |
| 2023-02-14 6:25 pm Unchanged |
2023-02-13 | 13D | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 760,000 9.070% |
0 (Unchanged) |
Filing History |
| 2023-02-06 5:43 pm Purchase |
2022-12-30 | 13G | Lumos Pharma, Inc. LUMO |
GOLDMAN SACHS GROUP INC GS |
469,402 5.600% |
469,402 (New Position) |
Filing History |
| 2023-01-24 12:58 pm Purchase |
2023-01-25 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 760,000 9.070% |
263,189 (+52.98%) |
Filing History |
| 2022-02-02 2:44 pm Unchanged |
2022-01-27 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,811 5.940% |
0 (Unchanged) |
Filing History |
| 2022-01-31 5:34 pm Purchase |
2022-01-27 | 13G | Lumos Pharma, Inc. LUMO |
Farb Daniel Stuart | 496,811 5.940% |
496,811 (New Position) |
Filing History |
| 2022-01-05 2:41 pm Sale |
2021-12-27 | 13D | Lumos Pharma, Inc. LUMO |
New Enterprise Associates 14, L.P. | 0 0.000% |
-524,030 (Position Closed) |
Filing History |
| 2021-08-30 5:21 pm Purchase |
2021-08-20 | 13D | Lumos Pharma, Inc. LUMO |
SHV Management Services II LP | 679,909 8.100% |
679,909 (New Position) |
Filing History |
| 2021-05-26 3:53 pm Sale |
2021-03-22 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 161,714 1.940% |
-774,577 (-82.73%) |
Filing History |
| 2021-02-12 3:56 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Lion Point Capital LP | 407,192 4.900% |
407,192 (New Position) |
Filing History |
| 2021-02-12 12:28 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 936,291 11.280% |
936,291 (New Position) |
Filing History |